AUSTIN, Texas, May 12, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today released an...
Read More Details
Finally We wish PressBee provided you with enough information of ( ADAR1 Capital Management Releases Investor Presentation Outlining Its Rationale for Withholding Votes From Directors Dr. Mary Ann Gray and Dr. Alpna Seth )
Also on site :
- Get an email about a ‘Lopez Voice Assistant Class Action Settlement'? Here's why
- Did India target Pakistan's nuclear site at Kirana Hills? IAF reacts
- PHOTOS: Travis Kelce Spotted Heading to Taylor Swift's Apartment